Annual Revenue Growth (Last Twelve Months): essapharma.com (EPIX)

Public company logo of ESSA Pharma (EPIX)

Geopolitical tensions are complicating international clinical trials and component logistics for ESSA Pharma Inc. (EPIX). However, the academic team of PhD biochemists is effectively advancing developments, as confirmed by the 12-month YoY sales change chart from the GURU.Markets dynamic system, where 0.00 shows the current metric value. The company's prospects rely on the implementation of robotic molecule screening and the automation of data digitization.

Sales Growth YoY (TTM): ESSA Pharma, Inc. (EPIX) for 02/11/2024 - 02/20/2024

Summary analytical data breakdowns for ESSA Pharma, Inc. (EPIX)

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Summary company analytics:essapharma.com
Brand item of ESSA Pharma

The indicator is calculated as the percentage ratio of current revenue over the last 12 months to the same period last year. This metric measures business expansion dynamics, allowing for an assessment of revenue scaling rates without waiting for quarterly reports. For ESSA Pharma Inc. (EPIX), this figure reflects the commercialization of oncology patent developments. By analyzing the annual growth in sales volume via TTM, an investor can see the impact of clinical trial successes on financial stability.